Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer
Chulalongkorn University
48 participants
Oct 1, 2025
INTERVENTIONAL
Conditions
Summary
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Eligibility
Inclusion Criteria5
- Male or female age more than 18 years
- No Diabetis mellitus disease and no taking diabetes medication
- Blood sugar level less than 126 mg/dl and HbA1C less than 6.5
- Can using Thai language
- Willing to participate in the study
Exclusion Criteria6
- Allergic to mulberry extract
- Take mulberry extract in 2 weeks before participate in this study
- Take medications that have effect on blood sugar level such as steroid in 2 weeks before participate in this study
- Have uncontrolled disease
- Have AST, ALT, ALP more than 3 times of normal value, or estimated Glomerular Filtration Rate less than 30 ml/min/1.73 m2)
- Pregnancy or lactation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
They took the Mulberry leaf extract capsule (DNJ 12mg) 3 times/day for 8 weeks.
They took the sample 3 times/day for 8 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07532135